DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)

DongKook Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	765,763	726,357	710,431	729,658	958,073	1,285,488
Market Cap Growth	-11.98%	2.24%	-2.63%	-23.84%	-25.47%	64.14%
Enterprise Value	821,779	792,360	751,610	743,265	932,778	1,201,020
Last Close Price	17250.00	16520.00	15966.70	16218.07	21076.18	28053.09
PE Ratio	13.30	11.95	15.19	13.79	19.03	22.99
Forward PE	11.12	10.99	10.99	10.99	10.99	10.99
PS Ratio	0.91	0.89	0.97	1.10	1.61	2.30
PB Ratio	1.09	1.07	1.18	1.31	1.90	2.82
P/TBV Ratio	1.33	1.27	1.33	1.48	2.14	3.18
P/FCF Ratio	16.15	14.88	93.28	-	-	65.92
P/OCF Ratio	10.67	9.55	17.00	17.84	21.46	21.75
EV/Sales Ratio	0.98	0.98	1.03	1.12	1.57	2.15
EV/EBITDA Ratio	7.21	7.32	8.54	8.02	11.58	12.29
EV/EBIT Ratio	9.71	9.92	11.24	10.11	14.76	14.54
EV/FCF Ratio	17.33	16.24	98.69	-	-	61.59
Debt / Equity Ratio	0.11	0.12	0.13	0.12	0.19	0.15
Debt / EBITDA Ratio	0.69	0.74	0.87	0.72	1.22	0.70
Debt / FCF Ratio	1.65	1.65	10.07	-	-	3.51
Asset Turnover	0.91	0.91	0.91	0.87	0.84	0.93
Inventory Turnover	2.46	2.45	2.48	2.53	2.69	3.17
Quick Ratio	1.38	1.26	1.34	1.49	1.40	2.15
Current Ratio	2.13	2.02	2.06	2.22	1.91	2.75
Return on Equity (ROE)	9.14%	9.72%	8.42%	10.33%	11.03%	13.76%
Return on Assets (ROA)	5.71%	5.57%	5.20%	6.05%	5.59%	8.55%
Return on Capital (ROIC)	7.21%	6.93%	6.41%	7.51%	7.02%	10.64%
Return on Capital Employed (ROCE)	11.40%	11.10%	10.50%	12.40%	11.90%	15.90%
Earnings Yield	7.51%	8.43%	6.64%	7.25%	5.25%	4.35%
FCF Yield	6.19%	6.72%	1.07%	-0.96%	-0.66%	1.52%
Dividend Yield	1.16%	1.21%	-	-	-	-
Payout Ratio	14.34%	13.58%	17.07%	15.22%	15.99%	12.79%
Buyback Yield / Dilution	0.07%	-0.01%	-0.02%	-0.01%	-	-
Total Shareholder Return	1.23%	1.20%	-0.02%	-0.01%	-	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.